Skip to content

Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control

Rôle du Cervelet et de l'Aire Motrice supplémentaire Dans le contrôle Postural au Cours de la Marche Chez l'Homme

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02976298
Acronym
CERESMARCHE
Enrollment
20
Registered
2016-11-29
Start date
2013-02-28
Completion date
2015-01-31
Last updated
2025-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transcranial Magnetic Stimulation

Keywords

cerebellum, supplementary motor area

Brief summary

In human, the physiology of gait and balance is not clearly established. By using functional imaging and electrophysiological techniques, various brain regions from the cortex to the midbrain area, including the cerebellum, have been identified as involved in such control. The specific role of these structures in both the capacity to go forward (locomotion) and stand upright (balance), but also in the different phases of the gait initiation process, are not known, however. In this study,the investigators aimed to assess the specific role of both the supplementary motor area (SMA) and the cerebellum in postural control during the initiation of gait. For this purpose, the investigators plan to study the gait initiation in 20 healthy subjects before and after functional inactivation (using inhibitory repetitive transcranial magnetic stimulation, rTMS) of the cerebellum or SMA. Biomechanical, kinematic and electromyographic parameters of the gait initiation will be recorded using a force platform, reflective markers with infrared cameras (VICON system) and lower limbs surface EMG electrodes.

Interventions

OTHERtranscranial magnetic stimulation

comparison of different conditions of transcranial magnetic stimulation

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-70 years * agree to participate to the study with signature of the informed consent * heathy insurance * normal clinical exam

Exclusion criteria

* previous medical history of neurological, rheumatological, orthopedic or psychiatric disorders * contra-indication to MRI or TMS * drug treatment that modifies the nervous central system excitability (antidepressant, antiepileptic, neuroleptic) * chronic alcoholism

Design outcomes

Primary

MeasureTime frameDescription
postural control during gait initiationchange between baseline and 5 minutes after transcranial magnetic stimulationbraking capacity

Secondary

MeasureTime frameDescription
duration of anticipatory postural adjustmentschange between baseline and 5 minutes after transcranial magnetic stimulationduration

Other

MeasureTime frameDescription
centre of foot pressure displacement during postural adjustmentschange between baseline and 5 minutes after transcranial magnetic stimulationcentre of foot pressure displacement measured by force platform
step lengthchange between baseline and 5 minutes after transcranial magnetic stimulationstep length
step velocitychange between baseline and 5 minutes after transcranial magnetic stimulationstep velocity
duration of electromyographic activity of the tibialis anterior muscleschange between baseline and 5 minutes after magnetic transcranial stimulation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026